$xbi i'm not a big market is gonna crash guy.. but seeing $spy on THE Mutton's first page has me thinking. Adumb1 cap charging 2 and 20% to be long spy.. classic grift
A new lawsuit has been filed against $NVO on behalf of a Pennsylvania resident who allegedly developed NAION (non-arteritic anterior ischemic optic neuropathy) after taking Wegovy.
Key points:
โข The lawsuit was filed on May 29, 2026.
โข NAION is a rare eye condition that can cause partial or permanent vision loss by reducing blood flow to the optic nerve.
โข The complaint cites studies that have reported an association between semaglutide and increased rates of NAION.
โข The plaintiff alleges Novo Nordisk failed to adequately warn patients and healthcare professionals about the potential risk.
It is important to note that the lawsuit contains allegations that have not been proven in court, and Novo Nordisk has previously stated that the overall benefit-risk profile of semaglutide remains positive.
Link: https://t.co/0SZklpfwHN
#stocks #Investing
Trump health adviser Dr. Oz: 160 additional drugs being added to the Trump Rx site. Medicare patients eligible for GLP-1 products will be able to get them for $50/month starting July 1.
Best month Iโve ever had. Iโve never disagreed with the macro more but just allowed things to play out.
I think we might be looking at the beginning of a biotech bull market as well.